`
`FDA grants three years of marketing exclusivity to ISTA's BROMDAY
`
`March 14, 2016
`
`637 people on this site
`
`
`
`
`
`powered by chartbeat
`
`LIFE SCIENCES & MEDICINE
`
`Other search tools:
`
`Drugs |
`
`Health |
`
`News
`
`Media Pack
`
`Contact Us
`
`Newsletters
`
`FDA grants three years of marketing exclusivity to
`ISTA's BROMDAY
`Published on November 18, 2010 at 12:39 AM · No Comments
`
`Recommend
`
`0
`
`Share
`
`7
`
`Tweet
`
`ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced the U.S. Food and Drug
`Administration (FDA) has granted the Company three years of marketing exclusivity for
`BROMDAY™ (bromfenac ophthalmic solution) 0.09%, as provided under the Drug Price
`Competition and Patent Term Restoration Act, commonly known as the HatchWaxman
`Act. BROMDAY (formerly referred to as XiDay), the first and only oncedaily
`prescription eye drop for the treatment of postoperative inflammation and reduction of
`ocular pain in patients who have undergone cataract extraction, was approved by the
`FDA in October of 2010. Under the HatchWaxman Act, the FDA may not approve an
`Abbreviated New Drug Application for a generic version of BROMDAY until October of
`2013.
`
`ISTA also announced it recently shipped the first orders of BROMDAY to wholesalers
`and expects BROMDAY to be available in pharmacies beginning the week of November
`22, 2010. The ISTA sales force has begun detailing BROMDAY to ophthalmologists,
`and the company expects to discontinue the twicedaily XIBROM product in early 2011.
`
`Source:
`ISTA Pharmaceuticals, Inc.
`
`Be the first to rate this post
`
`Posted in: Pharmaceutical News
`Tags: Allergy, AntiInflammatory, Cataract, Conjunctivitis, Contact Lens, Dry Eye, Glaucoma, New
`Drug Application, Pain
`
`Permalink | Comments (0)
`
`Prior News
`VX770 drug candidate improves lung function
`in people with cystic fibrosis
`
`Next News
`Rheonix receives U.S patent for microfluidic
`device
`
`Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體
`中文 | Nederlands | Norsk | Русский | Svenska | Polski
`
`Comments
`
`The opinions expressed here are the views of the writer and do not necessarily reflect the views and
`opinions of NewsMedical.Net.
`
`Post a new comment
`
`Login
`
`
`
`
`
`Quirky Comment Title (optional)
`
`Post
`
`Advertisement
`
`Trending Stories
`
`Maternal diet during
`pregnancy and lactation leads
`to epigenetic changes in…
`offspring
`Surprising bone health findings
`in women with restless legs
`syndrome
`Majority of breast cancer
`patients develop symptoms of
`posttraumatic stress disorder
`New procedure allows kidney
`transplants from incompatible
`donors
`Calgary researchers develop
`new class of nanomedicines to
`treat autoimmune diseases
`UCLAled researchers identify
`specific gene network that
`promotes repair in periphera…
`nervous system
`Latest News
`
`NIHfunded investigators
`develop therapeutic compound
`effective against malaria
`Tai chi exercise improves
`outcomes in older fallers
`
`Betablockers could have
`potential benefit for COPD
`patients
`Foundation Surgical Hospital of
`El Paso receives Center of
`Excellence Award in Nursing
`New research shows
`deficiencies in general
`palliative care for stroke…
`patients
`Ultrasonic 'piezosurgery'
`equipment reduces pain,
`swelling in patients undergoi…
`chin surgery
`
`Advertisement
`
`http://www.newsmedical.net/news/20101118/FDAgrantsthreeyearsofmarketingexclusivitytoISTAsBROMDAY.aspx
`
`1/2
`
`
`
`3/13/2016
`
`FDA grants three years of marketing exclusivity to ISTA's BROMDAY
`
`News Medical
`245,975 likes
`
`Like Page
`
`Share
`
`Be the first of your friends to like this
`
`News Medical
`
`Follow
`
`+1
`
`+ 4,622
`
`NewsMedical.Net provides this medical
`information service in accordance with these
`terms and conditions. Please note that medical
`information found on this website is designed
`to support, not to replace the relationship
`between patient and physician/doctor and the
`medical advice they may provide.
`
`News A to Z Drugs A to Z Health A to Z Clinical & Diagnostics Life Science & Laboratory
`Consumer Products News Archive Medical News Tweets Information RSS
`
`NewsMedical.net An AZoNetwork Site
`Owned and Operated by AZoM.com Limited Copyright 20002016
`
`This site complies with the HONcode standard for trustworthy health information:
`verify here.
`
`http://www.newsmedical.net/news/20101118/FDAgrantsthreeyearsofmarketingexclusivitytoISTAsBROMDAY.aspx
`
`2/2
`
`Page 2